April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Clarin-1 Expression In The Retina Using AAV Mediated Gene Delivery
Author Affiliations & Notes
  • Astra Dinculescu
    Ophthalmology, University of Florida, Gainesville, Florida
  • Yoshikazu Imanishi
    Pharmacology, Case Western Reserve University, Cleveland, Ohio
  • Frank M. Dyka
    Ophthalmology, University of Florida, Gainesville, Florida
  • Jianwen Liu
    Ophthalmology, University of Florida, Gainesville, Florida
  • Issam McDoom
    Ophthalmology, University of Florida, Gainesville, Florida
  • Xuan Liu
    Ophthalmology, University of Florida, Gainesville, Florida
  • Hanna Västinsalo
    Folkhälsan Institute of Genetics, Helsinki, Finland
  • Reetta Jalkanen
    Folkhälsan Institute of Genetics, Helsinki, Finland
  • Eeva-Marja Sankila
    Folkhälsan Institute of Genetics, Helsinki, Finland
  • William W. Hauswirth
    Ophthalmology, University of Florida, Gainesville, Florida
  • Footnotes
    Commercial Relationships  Astra Dinculescu, None; Yoshikazu Imanishi, None; Frank M. Dyka, None; Jianwen Liu, None; Issam McDoom, None; Xuan Liu, None; Hanna Västinsalo, None; Reetta Jalkanen, None; Eeva-Marja Sankila, None; William W. Hauswirth, AGTC (P)
  • Footnotes
    Support  Usher III Initiative, Inc.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3336. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Astra Dinculescu, Yoshikazu Imanishi, Frank M. Dyka, Jianwen Liu, Issam McDoom, Xuan Liu, Hanna Västinsalo, Reetta Jalkanen, Eeva-Marja Sankila, William W. Hauswirth; Clarin-1 Expression In The Retina Using AAV Mediated Gene Delivery. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3336.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Human Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by clarin-1 (CLRN1) gene mutations leading to progressive retinitis pigmentosa and sensorineural hearing loss. Here, we employ rAAV vectors for studies aimed at identifying which retinal cells express clarin-1 in the mouse retina.

Methods: : Three AAV type 8-733 (Y-F mutation at AAV capsid position 733) vectors containing 1, 2 or 3 kb of proximal mouse clarin promoter sequence driving mCherry reporter gene expression were injected into wild-type mouse eyes via a subretinal approach. Treated eyes were analyzed fundoscopically and histologically to determine the retinal pattern of fluorescent mCherry expression. In addition, the effects of a scAAV8-733 CBA vector expressing a hemagglutinin (HA)-tagged human clarin-1 (hClarin) on retinal structure and function were examined following subretinal injection.

Results: : The 1kb clarin promoter vector led to strong mCherry expression in both photoreceptor and RPE cells. Subretinal delivery of scAAV8-733 vector expressing hClarin (1010 vector genomes per injection) under control of a CBA promoter led to significant photoreceptor degeneration as evidenced by morphological and ERG analyses. This toxic effect was not seen with weaker vectors, such as conventional AAV2 expressing hClarin under the same CBA promoter. We also tested a 1:1000 dilution of the above scAAV8-733 (CBA)-hclarin vector up to 3 months after injection and found no ERG loss.

Conclusions: : Reporter mCherry expression patterns when driven by mouse clarin promoter sequences suggest that photoreceptors are the main source of clarin expression in the adult mouse retina. Additionally, there appears to be a critical threshold for Clarin expression, above which photoreceptor cell death occurs. Since it is known that endogenous Clarin expression is likely to be low, it may therefore be prudent to employ therapeutic vectors at titers that produce physiologic levels of this protein to avoid overexpression toxicity.

Keywords: retina • photoreceptors • gene transfer/gene therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×